1979
DOI: 10.1111/j.1600-065x.1979.tb00303.x
|View full text |Cite
|
Sign up to set email alerts
|

Immunobiology of a Spontaneous Murine B Cell Leukemia (BCL1)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
28
0

Year Published

1981
1981
2007
2007

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(30 citation statements)
references
References 21 publications
(17 reference statements)
2
28
0
Order By: Relevance
“…Animals were observed for signs or symptoms of tumor growth (massive splenomegaly), and time from cell injection to animal death was monitored as previously described. 22 The cause of death was determined by necropsy.…”
Section: In Vivo Experimentsmentioning
confidence: 99%
See 2 more Smart Citations
“…Animals were observed for signs or symptoms of tumor growth (massive splenomegaly), and time from cell injection to animal death was monitored as previously described. 22 The cause of death was determined by necropsy.…”
Section: In Vivo Experimentsmentioning
confidence: 99%
“…Animals were observed for signs or symptoms of tumor growth (massive splenomegaly), and time from cell injection to animal death was monitored as previously described. 22 The cause of death was determined by necropsy.To explore the capacity of the CD8 ϩ NKT cells to cause GVHD, recipient Balb/c mice were irradiated as above and transplanted with BM cells from C57BL/6 recipients with either splenocytes or expanded CD8 ϩ NKT cells from wild-type (WT) C57BL/6 or mutant strains of mice on the B6 background at the indicated dose. Typical signs and symptoms of GVHD were observed, including ruffled fur, diarrhea, hunchback appearance, weight loss, and survival.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…BCL 1 tumor cell passage and injection BCL 1 is a B-cell leukemia/lymphoma derived from BALB/c mice expressing a tumor-specific IgM-l surface Ig. 4,10 This cell line was maintained in vivo by serial passage in wildtype BALB/c mice as described previously. [10][11][12][13][14][15][16] A dose of 5 Â 10 2 BCL 1 cells from spleen of tumor-laden BALB/c mice was injected intravenously into transplanted BALB/c hosts and non-transplanted, sublethally irradiated or nonirradiated BALB/c controls.…”
Section: Analysis Of Splenic V B Subsetsmentioning
confidence: 99%
“…23 This cell line was maintained by serial passage in BALB/c mice as described previously. 23 BCL 1 cells (1 ϫ 10 6 ) from the spleen of BALB/c mice were injected intravenously into normal BALB/c recipients, to allow the lymphoma to grow in the recipients for 13 days before the conditioning treatment.…”
Section: Bcl 1 Tumor Cell Passage and Injectionmentioning
confidence: 99%